Biomolecular Screening - The Online Scientific Community

Selecting IVF Embryos for Normal Numbers of Chromosomes can Significantly Increase Pregnancy Rates
First randomized prospective study shows ongoing pregnancy rate after 20 weeks per cycle started of 69.1% in the 24sure treatment group vs 41.7% in the control group.

Promise of Structure-Based Drug Design for GPCRs
Heptares Therapeutics announces the recent publication of a major review of the state of the art for GPCR drug discovery and new insights that, for the first time, can be obtained from structural biology.

New Biomarkers Could Offer Vital Clues for Cancer Research
European funding for cancer research has led to some interesting results in recent years, says Carl-Johan Ivarsson, CEO at Qlucore.

Guidelines for Prostate Screening Widely Ignored, Study Finds
2008 recommendations from federal task force had no impact.

Researchers Turn Big Data Problems into Advanced Biology and Drug Discoveries
University of Illinois at Chicago and The Genome Analysis Centre in Norwich, UK leverage SGI(R) UV(TM) to accelerate drug discovery and complex problem analysis.

New Research on Zebrafish Brings a Cure for Hearing Loss Closer
Zebrafish to discover drugs that may lead to the restoration of hearing.

Completion of Alzheimer’s Plasma Biomarker Study
The preliminary results demonstrate significant diagnostic and prognostic utilities.

ERSPC Latest Findings Confirm Increased Mortality Benefit from Prostate Cancer Testing
Extended follow up needed to establish full impact of screening.

Broad Institute, Dana-Farber and Novartis Collaborate to Develop Cancer Cell Line Encyclopedia
Scientists have written the 'Book of Cancer Knowledge' to aid future research into drug discovery and personalized medicine.

Specificity Quantification of Biomolecular Recognition and its Implication for Drug Discovery
Highly efficient and specific biomolecular recognition requires both affinity and specificity. Here scientists developed a novel method SPA (SPecificity and Affinity) based on funneled energy landscape theory, with increased specificity on previous models.

Chemical Restriction Length Polymorphism (CLFP) for Detection and Characterization of Bacterial Pathogens Byron Brehm-Stecher, Iowa State University, speaking at Advances in Biosensors and Biotedection 2011.
Functional Interrogation of 'omics' Data Dr Kartiki V Desai, National Insitute of Biomedical Genomics, speaking at Screening Asia 2011.
Understanding Fat Metabolism at the Organism Level – A Comprehensive Metabolic Screen of C. elegans. Dr Jules Griffin, University of Cambridge, speaking at Advances in Metabolic Profiling 2011.
Actionable Biomarkers for Rheumatoid Arthritis Dr William Robinson, Stanford University, speaking at Microarray World Congress 2011.
The Potassium Channels Kv1.3 and KCa3.1 as Targets for Inflammatory Brain Pathologies Professor Heike Wulff, University of California, speaking at Ion Channel Targets 2011.
*Alpha2 Nicotinic Acetylcholine Receptors as a Therapeutic Target for Memory Enhancement** Dr Katumi Sumikawa, University of California, speaking at Ion Channel Targets 2011.
Smooth Muscle Kv7 (KCNQ) Potassium Channels: Important New Therapeutic Targets Professor Kenneth Byron, Loyola University Chigaco, speaking at Ion Channel Targets 2011.
Protons, Heat and Mechanical Force Converge to Gate Two-Pore Potassium Channels at the Selectivity Filter Dr Slav Bagriantsev, University of California, speaking at Ion Channel Targets 2011.
Background and Key Drivers Leading to Clinical Immunogenicity Dr Matthew Baker, Chief Scientific Officer at Antitope Ltd, speaking at Bioprocessing, Biologics and Biotherapeutics 2011.
Challenges for High Content Analysis of Infectious Diseases Anne Danckaert, Institut Pasteur, speaking at Screening Europe 2011

<<	1 2 3 4 5 6 7	>>
Showing Results 1 - 10 of 183